Research Archives - Page 5 of 21 - Canadian Alopecia Areata Foundation

Concert Pharmaceuticals begins THRIVE-AA2 phase 3 clinical trial for JAK inhibitors (CTP-543)

CANAAF is thrilled to share that Concert Pharmaceuticals has announced the launching of THRIVE-AA2, the second planned Phase 3 clinical

canaaf2022-05-19T17:54:12+00:00May 27th, 2021|Clinical Trials, Research|

International Clinical Trials Day May 20th, 2021 | #ICTD2021 May 20th is International Clinical Trials Day. Clinical trials help

canaaf2021-11-23T19:59:26+00:00May 20th, 2021|Clinical Trials|

This study is now closed. Thank you to all who completed the survey. The study results will be released at www.canaaf.org

canaaf2021-11-26T19:20:20+00:00March 24th, 2021|Research|